TY - JOUR
T1 - Tumor oxygenation after hyperthermia in the rat 13762 mammary carcinoma and the DU-145 human prostate carcinoma
AU - Teicher, Beverly A.
AU - Ara, Gulshan
AU - Takeuchi, Hideya
AU - Coleman, C. Norman
PY - 1997/3/1
Y1 - 1997/3/1
N2 - Tumor oxygenation was measured in the rat 13762 mammary carcinoma over a time course from 30 min to 3 days after hyperthermia treatment of 43°C, 30 min or 40°C, 80 min, while the animals breathed air, carbogen or after administration of a perflubron emulsion with air or carbogen breathing. Shortly (30 min and 3 h) after treatment with 43°C, 30 min, the 13762 tumors were more hypoxic, as determined by the percent of pO2 readings <5 mmHg and median pO2, than prior to treatment and by 24 h had returned to initial oxygenation. Administration of the perflubron emulsion and carbogen breathing abrogated the increase in hypoxia and improved tumor oxygenation. Athymic mice bearing the DU-145 human prostate carcinoma were treated with hyperthermia regimens 40°C, 41°C, 42°C or 43°C for 60 min and tumor oxygenation was then measured over a time course while the animals breathed air or carbogen. Shortly (30 min) after hyperthermia, the DU-145 tumors were more hypoxic than initially when the animals breathed air. Three days later, the DU-145 tumors treated with 41°C, 42°C or 43°C remained hypoxic but the tumors treated with 40°C were better oxygenated than initially. When the animals bearing the DU-145 tumor breathed carbogen during the tumor oxygenation measurements only tumors treated with 43°C were more hypoxic shortly after hyperthermia treatment. Three days after hyperthermia, the DU-145 tumors treated with 40°C and 43°C were better oxygenated than initially while those treated with 41°C and 42°C were less oxygenated when the animals breathed carbogen during the oxygen measurements. Thus, the effect of hyperthermia on tumor physiology can persist for days post treatment and vary with the temperature of the treatment.
AB - Tumor oxygenation was measured in the rat 13762 mammary carcinoma over a time course from 30 min to 3 days after hyperthermia treatment of 43°C, 30 min or 40°C, 80 min, while the animals breathed air, carbogen or after administration of a perflubron emulsion with air or carbogen breathing. Shortly (30 min and 3 h) after treatment with 43°C, 30 min, the 13762 tumors were more hypoxic, as determined by the percent of pO2 readings <5 mmHg and median pO2, than prior to treatment and by 24 h had returned to initial oxygenation. Administration of the perflubron emulsion and carbogen breathing abrogated the increase in hypoxia and improved tumor oxygenation. Athymic mice bearing the DU-145 human prostate carcinoma were treated with hyperthermia regimens 40°C, 41°C, 42°C or 43°C for 60 min and tumor oxygenation was then measured over a time course while the animals breathed air or carbogen. Shortly (30 min) after hyperthermia, the DU-145 tumors were more hypoxic than initially when the animals breathed air. Three days later, the DU-145 tumors treated with 41°C, 42°C or 43°C remained hypoxic but the tumors treated with 40°C were better oxygenated than initially. When the animals bearing the DU-145 tumor breathed carbogen during the tumor oxygenation measurements only tumors treated with 43°C were more hypoxic shortly after hyperthermia treatment. Three days after hyperthermia, the DU-145 tumors treated with 40°C and 43°C were better oxygenated than initially while those treated with 41°C and 42°C were less oxygenated when the animals breathed carbogen during the oxygen measurements. Thus, the effect of hyperthermia on tumor physiology can persist for days post treatment and vary with the temperature of the treatment.
KW - 13762 mammary carcinoma
KW - DU-145 prostate carcinoma
KW - hyperthermia
KW - tumor oxygenation
UR - http://www.scopus.com/inward/record.url?scp=0030984234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030984234&partnerID=8YFLogxK
M3 - Review article
C2 - 21533394
AN - SCOPUS:0030984234
SN - 1019-6439
VL - 10
SP - 437
EP - 442
JO - International journal of oncology
JF - International journal of oncology
IS - 3
ER -